APO Research
Talk to an analyst

APO RESEARCH · REPORT

CGRP Monoclonal Antibodies

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global CGRP Monoclonal Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025182 pages

Choose your research edition.

Industry ResearchCGRP Monoclonal Antibodies Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal CGRP Monoclonal Antibodies Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal CGRP Monoclonal Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CGRP Monoclonal Antibodies Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal CGRP Monoclonal Antibodies Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global CGRP Monoclonal Antibodies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for CGRP Monoclonal Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for CGRP Monoclonal Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CGRP Monoclonal Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for CGRP Monoclonal Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of CGRP Monoclonal Antibodies include Alder Therapeutics, Amgen Inc., Daiichi Sankyo Co., Ltd., Pfizer Inc., Lilly Inc., Lundbeck, Novartis International AG and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global CGRP Monoclonal Antibodies market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of CGRP Monoclonal Antibodies and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents CGRP Monoclonal Antibodies revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CGRP Monoclonal Antibodies market size, projected growth trends, production technologies, key applications, and end-use industries.

CGRP Monoclonal Antibodies Segment by Company

Alder Therapeutics

Amgen Inc.

Daiichi Sankyo Co., Ltd.

Pfizer Inc.

Lilly Inc.

Lundbeck

Novartis International AG

Teva

CGRP Monoclonal Antibodies Segment by Type

Erenumab

Fremanezumab

Galcanezumab

Eptinezumab

CGRP Monoclonal Antibodies Segment by Application

Specialty Clinic

Hospital

Others

CGRP Monoclonal Antibodies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CGRP Monoclonal Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CGRP Monoclonal Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CGRP Monoclonal Antibodies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CGRP Monoclonal Antibodies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CGRP Monoclonal Antibodies industry.

Chapter 3: Detailed analysis of CGRP Monoclonal Antibodies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CGRP Monoclonal Antibodiesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CGRP Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Erenumab Table 3. Key Players of Fremanezumab Table 4. Key Players of Galcanezumab Table 3. Key Players of Eptinezumab Table 4. Global CGRP Monoclonal Antibodies Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Specialty Clinic Table 6. Key Players of Hospital Table 7. Key Players of Others Table 8. Global CGRP Monoclonal Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global CGRP Monoclonal Antibodies Market Size by Region (2021-2026) & (US$ Million) Table 10. Global CGRP Monoclonal Antibodies Market Share by Region (2021-2026) Table 11. Global CGRP Monoclonal Antibodies Market Size by Region (2027-2032) & (US$ Million) Table 12. Global CGRP Monoclonal Antibodies Market Share by Region (2027-2032) Table 13. CGRP Monoclonal Antibodies Industry Trends Table 14. CGRP Monoclonal Antibodies Industry Drivers Table 15. CGRP Monoclonal Antibodies Industry Opportunities and Challenges Table 16. CGRP Monoclonal Antibodies Industry Restraints Table 17. Global CGRP Monoclonal Antibodies Revenue by Company (US$ Million) & (2021-2026) Table 18. Global CGRP Monoclonal Antibodies Revenue Market Share by Company (2021-2026) Table 19. Global CGRP Monoclonal Antibodies Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global CGRP Monoclonal Antibodies Key Company Head Office and Area Served Table 21. Global CGRP Monoclonal Antibodies Company, Product Type & Application Table 22. Global CGRP Monoclonal Antibodies Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global CGRP Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global CGRP Monoclonal Antibodies Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 27. Global CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 28. Global CGRP Monoclonal Antibodies Revenue Market Share by Type (2021-2026) Table 29. Global CGRP Monoclonal Antibodies Revenue Market Share by Type (2027-2032) Table 30. Global CGRP Monoclonal Antibodies Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 32. Global CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 33. Global CGRP Monoclonal Antibodies Revenue Market Share by Application (2021-2026) Table 34. Global CGRP Monoclonal Antibodies Revenue Market Share by Application (2027-2032) Table 35. Alder Therapeutics Company Information Table 36. Alder Therapeutics Business Overview Table 37. Alder Therapeutics CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Alder Therapeutics CGRP Monoclonal Antibodies Product Portfolio Table 39. Alder Therapeutics Recent Development Table 40. Amgen Inc. Company Information Table 41. Amgen Inc. Business Overview Table 42. Amgen Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Amgen Inc. CGRP Monoclonal Antibodies Product Portfolio Table 44. Amgen Inc. Recent Development Table 45. Daiichi Sankyo Co., Ltd. Company Information Table 46. Daiichi Sankyo Co., Ltd. Business Overview Table 47. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Portfolio Table 49. Daiichi Sankyo Co., Ltd. Recent Development Table 50. Pfizer Inc. Company Information Table 51. Pfizer Inc. Business Overview Table 52. Pfizer Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Inc. CGRP Monoclonal Antibodies Product Portfolio Table 54. Pfizer Inc. Recent Development Table 55. Lilly Inc. Company Information Table 56. Lilly Inc. Business Overview Table 57. Lilly Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Lilly Inc. CGRP Monoclonal Antibodies Product Portfolio Table 59. Lilly Inc. Recent Development Table 60. Lundbeck Company Information Table 61. Lundbeck Business Overview Table 62. Lundbeck CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Lundbeck CGRP Monoclonal Antibodies Product Portfolio Table 64. Lundbeck Recent Development Table 65. Novartis International AG Company Information Table 66. Novartis International AG Business Overview Table 67. Novartis International AG CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Novartis International AG CGRP Monoclonal Antibodies Product Portfolio Table 69. Novartis International AG Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Teva CGRP Monoclonal Antibodies Product Portfolio Table 74. Teva Recent Development Table 75. North America CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 76. North America CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 77. North America CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 78. North America CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 79. North America CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America CGRP Monoclonal Antibodies Market Size by Country (2021-2026) Table 81. North America CGRP Monoclonal Antibodies Market Size by Country (2027-2032) Table 82. Europe CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe CGRP Monoclonal Antibodies Market Size by Country (2021-2026) Table 88. Europe CGRP Monoclonal Antibodies Market Size by Country (2027-2032) Table 89. China CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 90. China CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 91. China CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 92. China CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia CGRP Monoclonal Antibodies Market Size by Country (2021-2026) Table 99. Asia CGRP Monoclonal Antibodies Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. CGRP Monoclonal Antibodies Product Image Figure 2. Global CGRP Monoclonal Antibodies Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global CGRP Monoclonal Antibodies Market Share by Type: 2025 VS 2032 Figure 4. Erenumab Image Figure 5. Fremanezumab Image Figure 6. Galcanezumab Image Figure 7. Eptinezumab Image Figure 8. Global CGRP Monoclonal Antibodies Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global CGRP Monoclonal Antibodies Market Share by Application: 2025 VS 2032 Figure 10. Specialty Clinic Image Figure 11. Hospital Image Figure 12. Others Image Figure 13. Global CGRP Monoclonal Antibodies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 15. Global CGRP Monoclonal Antibodies Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global CGRP Monoclonal Antibodies Market Share by Players in 2025 Figure 18. Global Top 5 and 10 CGRP Monoclonal Antibodies Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global CGRP Monoclonal Antibodies Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global CGRP Monoclonal Antibodies Revenue Market Share by Type (2021-2032) Figure 22. Global CGRP Monoclonal Antibodies Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global CGRP Monoclonal Antibodies Revenue Market Share by Application (2021-2032) Figure 24. North America CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 25. North America CGRP Monoclonal Antibodies Market Share by Type (2021-2032) Figure 26. North America CGRP Monoclonal Antibodies Market Share by Application (2021-2032) Figure 27. North America CGRP Monoclonal Antibodies Market Share by Country (2021-2032) Figure 28. United States CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 29. Canada CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 30. Mexico CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 31. Europe CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 32. Europe CGRP Monoclonal Antibodies Market Share by Type (2021-2032) Figure 33. Europe CGRP Monoclonal Antibodies Market Share by Application (2021-2032) Figure 34. Europe CGRP Monoclonal Antibodies Market Share by Country (2021-2032) Figure 35. Germany CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 36. France CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 37. U.K. CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 38. Italy CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 39. Russia CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 41. China CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 42. China CGRP Monoclonal Antibodies Market Share by Type (2021-2032) Figure 43. China CGRP Monoclonal Antibodies Market Share by Application (2021-2032) Figure 44. Asia CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 45. Asia CGRP Monoclonal Antibodies Market Share by Type (2021-2032) Figure 46. Asia CGRP Monoclonal Antibodies Market Share by Application (2021-2032) Figure 47. Asia CGRP Monoclonal Antibodies Market Share by Country (2021-2032) Figure 48. Japan CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 49. South Korea CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 52. India CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 53. Australia CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Country (2021-2032) Figure 58. Brazil CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 59. South Africa CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 61. Turkey CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 62. Argentina CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 63. UAE CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 64. Egypt CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 65. Chile CGRP Monoclonal Antibodies Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Erenumab
  • Fremanezumab
  • Galcanezumab
  • Eptinezumab
Applications
  • Specialty Clinic
  • Hospital
  • Others
Companies covered
  • Alder Therapeutics
  • Amgen Inc.
  • Daiichi Sankyo Co., Ltd.
  • Pfizer Inc.
  • Lilly Inc.
  • Lundbeck
  • Novartis International AG
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global CGRP Monoclonal Antibodies Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Erenumab
  5. 1.2.3 Fremanezumab
  6. 1.2.4 Galcanezumab
  7. 1.2.5 Eptinezumab
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global CGRP Monoclonal Antibodies Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Specialty Clinic
  11. 1.3.3 Hospital
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global CGRP Monoclonal Antibodies Growth Trends by Region
  15. 1.5.1 Global CGRP Monoclonal Antibodies Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 CGRP Monoclonal Antibodies Market Size by Region (2021-2026)
  17. 1.5.3 CGRP Monoclonal Antibodies Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global CGRP Monoclonal Antibodies Market Dynamics
  1. 2.1 CGRP Monoclonal Antibodies Industry Trends
  2. 2.2 CGRP Monoclonal Antibodies Industry Drivers
  3. 2.3 CGRP Monoclonal Antibodies Industry Opportunities and Challenges
  4. 2.4 CGRP Monoclonal Antibodies Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global CGRP Monoclonal Antibodies Revenue by Company (2021-2026)
  2. 3.2 Global CGRP Monoclonal Antibodies Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global CGRP Monoclonal Antibodies Key Company Head office and Area Served
  4. 3.4 Global CGRP Monoclonal Antibodies Company, Product Type & Application
  5. 3.5 Global CGRP Monoclonal Antibodies Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global CGRP Monoclonal Antibodies Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 CGRP Monoclonal Antibodies Players Market Share by Revenue in 2025
  9. 3.6.3 2025 CGRP Monoclonal Antibodies Tier 1, Tier 2, and Tier 3
4 CGRP Monoclonal Antibodies Market by Type
  1. 4.1 Global CGRP Monoclonal Antibodies Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global CGRP Monoclonal Antibodies Market Size by Type (2021-2032)
  3. 4.3 Global CGRP Monoclonal Antibodies Market Size Share by Type (2021-2032)
5 CGRP Monoclonal Antibodies Market by Application
  1. 5.1 Global CGRP Monoclonal Antibodies Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global CGRP Monoclonal Antibodies Market Size by Application (2021-2032)
  3. 5.3 Global CGRP Monoclonal Antibodies Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Alder Therapeutics
  2. 6.1.1 Alder Therapeutics Company Information
  3. 6.1.2 Alder Therapeutics Business Overview
  4. 6.1.3 Alder Therapeutics CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Alder Therapeutics CGRP Monoclonal Antibodies Product Portfolio
  6. 6.1.5 Alder Therapeutics Recent Developments
  7. 6.2 Amgen Inc.
  8. 6.2.1 Amgen Inc. Company Information
  9. 6.2.2 Amgen Inc. Business Overview
  10. 6.2.3 Amgen Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Amgen Inc. CGRP Monoclonal Antibodies Product Portfolio
  12. 6.2.5 Amgen Inc. Recent Developments
  13. 6.3 Daiichi Sankyo Co., Ltd.
  14. 6.3.1 Daiichi Sankyo Co., Ltd. Company Information
  15. 6.3.2 Daiichi Sankyo Co., Ltd. Business Overview
  16. 6.3.3 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Portfolio
  18. 6.3.5 Daiichi Sankyo Co., Ltd. Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc. CGRP Monoclonal Antibodies Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Lilly Inc.
  26. 6.5.1 Lilly Inc. Company Information
  27. 6.5.2 Lilly Inc. Business Overview
  28. 6.5.3 Lilly Inc. CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lilly Inc. CGRP Monoclonal Antibodies Product Portfolio
  30. 6.5.5 Lilly Inc. Recent Developments
  31. 6.6 Lundbeck
  32. 6.6.1 Lundbeck Company Information
  33. 6.6.2 Lundbeck Business Overview
  34. 6.6.3 Lundbeck CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lundbeck CGRP Monoclonal Antibodies Product Portfolio
  36. 6.6.5 Lundbeck Recent Developments
  37. 6.7 Novartis International AG
  38. 6.7.1 Novartis International AG Company Information
  39. 6.7.2 Novartis International AG Business Overview
  40. 6.7.3 Novartis International AG CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Novartis International AG CGRP Monoclonal Antibodies Product Portfolio
  42. 6.7.5 Novartis International AG Recent Developments
  43. 6.8 Teva
  44. 6.8.1 Teva Company Information
  45. 6.8.2 Teva Business Overview
  46. 6.8.3 Teva CGRP Monoclonal Antibodies Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Teva CGRP Monoclonal Antibodies Product Portfolio
  48. 6.8.5 Teva Recent Developments
7 North America
  1. 7.1 North America CGRP Monoclonal Antibodies Market Size (2021-2032)
  2. 7.2 North America CGRP Monoclonal Antibodies Market Size by Type
  3. 7.2.1 North America CGRP Monoclonal Antibodies Market Size by Type (2021-2026)
  4. 7.2.2 North America CGRP Monoclonal Antibodies Market Size by Type (2027-2032)
  5. 7.2.3 North America CGRP Monoclonal Antibodies Market Share by Type (2021-2032)
  6. 7.3 North America CGRP Monoclonal Antibodies Market Size by Application
  7. 7.3.1 North America CGRP Monoclonal Antibodies Market Size by Application (2021-2026)
  8. 7.3.2 North America CGRP Monoclonal Antibodies Market Size by Application (2027-2032)
  9. 7.3.3 North America CGRP Monoclonal Antibodies Market Share by Application (2021-2032)
  10. 7.4 North America CGRP Monoclonal Antibodies Market Size by Country
  11. 7.4.1 North America CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America CGRP Monoclonal Antibodies Market Size by Country (2021-2026)
  13. 7.4.3 North America CGRP Monoclonal Antibodies Market Size by Country (2027-2032)
  14. 7.4.4 North America CGRP Monoclonal Antibodies Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe CGRP Monoclonal Antibodies Market Size (2021-2032)
  2. 8.2 Europe CGRP Monoclonal Antibodies Market Size by Type
  3. 8.2.1 Europe CGRP Monoclonal Antibodies Market Size by Type (2021-2026)
  4. 8.2.2 Europe CGRP Monoclonal Antibodies Market Size by Type (2027-2032)
  5. 8.2.3 Europe CGRP Monoclonal Antibodies Market Share by Type (2021-2032)
  6. 8.3 Europe CGRP Monoclonal Antibodies Market Size by Application
  7. 8.3.1 Europe CGRP Monoclonal Antibodies Market Size by Application (2021-2026)
  8. 8.3.2 Europe CGRP Monoclonal Antibodies Market Size by Application (2027-2032)
  9. 8.3.3 Europe CGRP Monoclonal Antibodies Market Share by Application (2021-2032)
  10. 8.4 Europe CGRP Monoclonal Antibodies Market Size by Country
  11. 8.4.1 Europe CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe CGRP Monoclonal Antibodies Market Size by Country (2021-2026)
  13. 8.4.3 Europe CGRP Monoclonal Antibodies Market Size by Country (2027-2032)
  14. 8.4.4 Europe CGRP Monoclonal Antibodies Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China CGRP Monoclonal Antibodies Market Size (2021-2032)
  2. 9.2 China CGRP Monoclonal Antibodies Market Size by Type
  3. 9.2.1 China CGRP Monoclonal Antibodies Market Size by Type (2021-2026)
  4. 9.2.2 China CGRP Monoclonal Antibodies Market Size by Type (2027-2032)
  5. 9.2.3 China CGRP Monoclonal Antibodies Market Share by Type (2021-2032)
  6. 9.3 China CGRP Monoclonal Antibodies Market Size by Application
  7. 9.3.1 China CGRP Monoclonal Antibodies Market Size by Application (2021-2026)
  8. 9.3.2 China CGRP Monoclonal Antibodies Market Size by Application (2027-2032)
  9. 9.3.3 China CGRP Monoclonal Antibodies Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia CGRP Monoclonal Antibodies Market Size (2021-2032)
  2. 10.2 Asia CGRP Monoclonal Antibodies Market Size by Type
  3. 10.2.1 Asia CGRP Monoclonal Antibodies Market Size by Type (2021-2026)
  4. 10.2.2 Asia CGRP Monoclonal Antibodies Market Size by Type (2027-2032)
  5. 10.2.3 Asia CGRP Monoclonal Antibodies Market Share by Type (2021-2032)
  6. 10.3 Asia CGRP Monoclonal Antibodies Market Size by Application
  7. 10.3.1 Asia CGRP Monoclonal Antibodies Market Size by Application (2021-2026)
  8. 10.3.2 Asia CGRP Monoclonal Antibodies Market Size by Application (2027-2032)
  9. 10.3.3 Asia CGRP Monoclonal Antibodies Market Share by Application (2021-2032)
  10. 10.4 Asia CGRP Monoclonal Antibodies Market Size by Country
  11. 10.4.1 Asia CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia CGRP Monoclonal Antibodies Market Size by Country (2021-2026)
  13. 10.4.3 Asia CGRP Monoclonal Antibodies Market Size by Country (2027-2032)
  14. 10.4.4 Asia CGRP Monoclonal Antibodies Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type
  3. 11.2.1 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application
  7. 11.3.1 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country
  11. 11.4.1 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa CGRP Monoclonal Antibodies Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst